December 17, 2019 11:56 am
The homegrown pharma major on Monday said it has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis.
November 28, 2015 1:36 am
Delhi HC refused to issue any injunction against Cipla restraining it from manufacturing the medicine, after observing that the life of the patent granted to Roche was ending in March 2016.
September 05, 2015 3:07 am
Cipla will as a result of these acquisitions gain multiple products in the areas of anti-infectives, diabetes and central nervous system disorders.
March 11, 2015 1:50 am
Cipla had challenged the patent, arguing that Tiotropium bromide monohydrate, sold under the brand name Spiriva.
January 14, 2015 8:40 am
Cipla had last year started manufacturing and selling a generic drug using the Indacaterol maleate salt.
January 10, 2015 2:24 am
The firm has been selling the drug in India under the trademark ‘Onbrez’ through Lupin since 2010.
December 17, 2014 1:06 am
Novartis has also sought damages and payment for infringing the patented pharmaceutical product.
April 26, 2014 12:20 am
The pharmaceutical industry needs to shed its archaic blockbuster model.
February 18, 2014 3:33 am
A look at the 30 bluechip companies that form the benchmark Sensex at the Bombay Stock Exchange reveals that over one third or 11 companies including Reliance Industries, TCS, ONGC and L&T do not have a woman director.
October 25, 2013 4:57 pm
The BSE Sensex fell 42 points amid profit booking today.
Express Wanderlust: Here's why March is a great time to visit Mathura